Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. – Cost Effective Supplements

Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

Quick navigation

Link
Conclusion
Supplements
Functions
Systems

Link to full study

http://www.ncbi.nlm.nih.gov/pubmed/21939614

Conclusion of this study

Supplements containing EPA ≥ 60% of total EPA + DHA, in a dose range of 200 to 2,200 mg/d of EPA in excess of DHA, were effective against primary depression. Translational studies are needed to determine the mechanisms of EPA's therapeutic benefit.